COVETRUS NORTH AMERICA, LLC

Covetrus North America, LLC specializes in the manufacturing and wholesale distribution of specialized pharmaceuticals, veterinary therapeutics, and medical-surgical supplies for federal agencies. Their core capabilities include the production of controlled substances such as ketamine hydrochloride and euthanasia solutions, as well as the supply of veterinary rabies vaccines and blood typing test kits. The company demonstrates deep technical expertise in GMP-compliant pharmaceutical formulation, sterile product manufacturing, and secure handling of regulated substances under DEA oversight. Their ability to deliver mission-critical medical countermeasures with strict chain-of-custody protocols positions them as a trusted provider for defense and veterinary health applications requiring precision, regulatory adherence, and rapid logistics support. The contractor maintains a primary relationship with the Department of Defense, supplying pharmaceuticals and medical devices for military veterinary services, research programs, and operational readiness. Contracts consistently involve controlled substances and biological agents used in field medicine, animal health management, and biomedical research, indicating a long-standing, mission-aligned partnership with DoD medical and logistics components. Industry focus centers on NAICS 325412 (Pharmaceutical Preparation Manufacturing), with secondary activity in surgical appliance manufacturing and professional equipment wholesaling. This reflects a niche positioning as a supplier of high-integrity, regulated medical products—particularly for veterinary and defense applications—rather than broad commercial healthcare distribution. Their work supports biosecurity, animal health, and clinical research needs within federal operational environments. Covetrus North America, LLC is a limited liability corporation headquartered in Dublin, Ohio, with no public certifications listed. Operating as a private entity without small business or socioeconomic designations, the company leverages its manufacturing and distribution infrastructure to serve specialized government markets, primarily through direct supply agreements with defense and federal health entities.